Evofem investor presentation

Author: owpy

August undefined, 2024

WebSecurities Purchase Agreement On April 5, 2024, Evofem Biosciences, Inc., a Delaware corporation (the “ Company ”) entered into a securities purchase agreement (“ SPA ”), with certain investors (the “ Investors ”) providing for the sale and issuance of senior subordinate convertible notes due in the aggregate original principal amount of … WebAug 4, 2024 · SAN DIEGO, Aug. 4, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and six-month periods ended June...

Evofem InvestorRoom - Investors Home

WebNov 18, 2024 · 3 ©2024 Evofem Biosciences, Inc.© 2024 Evofem Biosciences, Inc. For investor discussions only. Evofem Biosciences 101 • Commercial-stage biopharmaceutical company • Mission: to improve women’s lives by developing and commercializing innovative prescription products to address critical unmet needs in women’s sexual and reproductive ... WebJan 23, 2024 · January 23, 2024 OTCQB: EVFM EVFM: KEY INVESTMENT CONSIDERATIONS DIFFERENTIATED, INNOVATIVE FDA-APPROVED PRODUCT FOCUSED ON GROWTH IN $7.9 BILLION U.S. CONTRACEPTIVE MARKET •Q3 2024 was Evofem’s fourth consecutive quarter of net sales growth CONTINUED SUCCESS … spiced cranberry chutney recipe

Investor Contact - Evofem Biosciences, Inc.

WebOct 6, 2024 · Multi-billion $$ addressable U.S. market opportunity for current and late-stage investigational indications Shattering the hormone glass ceilingwith hormone-free, on … WebSep 5, 2024 · Evofem Biosciences (EVFM) Investor Presentation - Slideshow (OTCMKTS:EVFM) Seeking Alpha Healthcare Evofem Biosciences (EVFM) Investor Presentation - Slideshow Sep. 05, 2024 3:03 PM ET... WebJul 28, 2024 · Evofem Biosciences to Report Second Quarter 2024 Results and Provide Corporate Update on Thursday, August 4, 2024 - read this article along with other careers information, tips and advice on BioSpace Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights … spiced cranberry sauce with zinfandel

SAUNDRA PELLETIER CHIEF EXECUTIVE OFFICER JANUARY23, …

Evofem investor presentation

Revolutionizing Women’s Sexual and Reproductive Health

WebMay 4, 2024 · SAN DIEGO, May 4, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the three-month period ended March 31, 2024.... WebInvestors. Investor Overview; Events & Presentations; Press Releases; Stock Information; Financial Information. SEC Filings; Analyst Coverage; Corporate Governance. …

Did you know?

Web5 ©2024 Evofem Biosciences, Inc.©2024 Evofem Biosciences, Inc. For investor discussions only. The Unmet Need for a Non-Hormonal Contraceptive. Of the ~47M women at-risk for pregnancy ~17M segment out as potential adopters ~30M. 9M. 8M ~17M • Seeking/open to alternatives to hormonal contraception WebAbout Earnings Date. Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information …

WebNov 27, 2024 · Evofem’sfilings from time to time with the U.S. Securities and Exchange Commission. The forward looking statements in this presentation represent Evofem’sviews only as of the date of this presentation, November 27, 2024, and Evofem undertakes no obligation to update or review any WebNov 15, 2024 · © 2024 Evofem Biosciences, Inc. For investor discussions only. Page 4 Balance Sheet Highlights $23.9 M for use in ongoing operations as of September 30, …

WebApr 25, 2024 · SAN DIEGO, April 25, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the first... Web12400 High Bluff Drive, Suite 600 San Diego, California 92130 1.858.550.1900

WebSep 5, 2024 · Evofem Biosciences (EVFM) Investor Presentation - Slideshow. The following slide deck was published by Evofem Biosciences, Inc. in conjunction with this …

WebApr 24, 2024 · Investor Contact Amy Raskopf Evofem Biosciences, Inc. [email protected]: (917) 673-5775 Media Contact Cara Miller Evofem Biosciences, Inc. [email protected] O: (858) 550-1900 x272 spiced cream cheese spreadWebOct 7, 2024 · Investor Relations Contact Amy Raskopf Evofem Biosciences, Inc. [email protected] Mobile: (917) 673-5775. Media Contact Ellen Thomas Evofem Biosciences, Inc. [email protected] Mobile: (718) 490 ... spiced cranberry palomaWebMay 4, 2024 · Greetings, and welcome to the Evofem Biosciences’ First Quarter of 2024 Financial Results Call. At this time, all participants are in a listen only mode. A brief … spiced cranberry spriteWebSep 12, 2024 · The investor presentation cites a multi-billion dollar market opportunity for current and late stage investigational indications. Evofem has set the bar by which their … spiced cranberry syrupWebInvestors. Investor Overview; Events & Presentations; Press Releases; Stock Information; Financial Information. SEC Filings; Analyst Coverage; Corporate … spiced cubeWebEvofem Biosciences has raised a total of $470.8M in funding over 16 rounds. Their latest funding was raised on May 20, 2024 from a Post-IPO Equity round. Evofem Biosciences … spiced cranberry sauceWebJun 8, 2024 · statements in this presentation are qualified in their entirety by this cautionary statement. Evofem Biosciences (Nasdaq: EVFM) Commercial-stage biopharmaceutical … spiced culinary creations